Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Profession

Business & Regulation Profession

Welcoming Change

| Maryam Mahdi

Tony Hitchcock discusses his career and the evolution of the gene therapy market.

Manufacture Facilities

Innovation in Biopharma Education

| James Strachan

The Jefferson Institute for Bioprocessing is up and running after just two years. How did they do it? And what courses are on offer?

Business & Regulation Profession

The Interface Between Art and Science

| Maryam Mahdi

When art and science meet, true inspiration can be found and tapped into.

Manufacture Small Molecules

The Master of Small Molecule Design

| Stephanie Sutton

Sitting Down With… Brian Henry, Vice President of Drug Product Design, Pharmaceutical Sciences department at Pfizer.

Business & Regulation Profession

Foresight is 20/20: Lessons Learned with Claudia Zylberberg

| James Strachan

Claudia Zylberberg reveals her career lessons learned and offers her perspective on the now booming advanced therapies industry.

Business & Regulation Business Practice

Expect the Unexpected

| Yong Guo

Scientific careers are inherently unpredictable, but there are a number of steps we can take to be prepared.

Business & Regulation Business Practice

Fourth Time’s a Charm

| James Strachan

We sit down with Nigel Theobald, Chief Executive, N4 Pharma. He tells us the story of his career and offers some advice for budding entrepreneurs.

Business & Regulation Business Practice

Business in Brief

| Maryam Mahdi

Scouting for new leadership, prices hikes and successful acquisitions. What’s new for pharma in business?

Business & Regulation Small Molecules

And for 2020...

| Stephanie Sutton

Nominations are now open for The Medicine Maker 2020 Power List.

Business & Regulation Business Practice

Solutions In... Human Antibodies

| Maryam Mahdi

John McCafferty, CEO of IONTAS, explains how his company’s work in mammalian cells could bring biopharmaceuticals to market faster.

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register